Evidence map›Paper›PMID 26472062›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2015

Graphene Oxide Nanosheets Modified with Single-Domain Antibodies for Rapid and Efficient Capture of Cells.

Guan-Yu Chen, Zeyang Li, Christopher S Theile, Neelkanth M Bardhan, Priyank V Kumar, Joao N Duarte, Takeshi Maruyama, Ali Rashidfarrokh, Angela M Belcher, Hidde L Ploegh

Abstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Applications of Nanosheets in Frontier Cellular Research.Nanomaterials (Basel, Switzerland) · 2018
    Review
  4. Current Conjugation Methods for Immunosensors.Nanomaterials (Basel, Switzerland) · 2018
    Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Guan-Yu ChenWhitehead Institute for Biomedical Research, Cambridge, MA 02142 (USA).
Zeyang LiDepartment of Chemistry, Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology, Cambridge, MA 02139 (USA).
Christopher S TheileWhitehead Institute for Biomedical Research, Cambridge, MA 02142 (USA).
Neelkanth M BardhanDepartment of Materials Science and Engineering, The David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139 (USA).
Priyank V KumarDepartment of Materials Science and Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139 (USA).
Joao N DuarteWhitehead Institute for Biomedical Research, Cambridge, MA 02142 (USA).
Takeshi MaruyamaWhitehead Institute for Biomedical Research, Cambridge, MA 02142 (USA).
Ali RashidfarrokhWhitehead Institute for Biomedical Research, Cambridge, MA 02142 (USA).
Angela M BelcherDepartment of Materials Science and Engineering, Department of Biological Engineering, The David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139 (USA).
Hidde L PloeghDepartment of Biology, Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology, Cambridge, MA 02142 (USA). ploegh@wi.mit.edu.

Funding

A new strategy to disrupt protein-protein interactions in eukaryotic cells.DP1GM106409 · NIGMS · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI PLOEGH, HIDDE L. · 2012 to 2016
$4.8M
Sortase-mediated protein engineering for the study of host-pathogen interactionsR01AI087879 · NIAID · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI PLOEGH, HIDDE L. · 2010 to 2019
$4.5M
Non-invasive imaging of the immune response based on the use of isotopically labeled single domain antibody fragmentsR21AI117373 · NIAID · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI PLOEGH, HIDDE L. · 2015 to 2016
$536k
NIAID NIH HHS R01 AI087879NIAID NIH HHS R21 AI117373NIGMS NIH HHS DP1 GM106409
6 · The paper itself

Abstract

Peripheral blood can provide valuable information on an individual's immune status. Cell-based assays typically target leukocytes and their products. Characterization of leukocytes from whole blood requires their separation from the far more numerous red blood cells.1 Current methods to classify leukocytes, such as recovery on antibody-coated beads or fluorescence-activated cell sorting require long sample preparation times and relatively large sample volumes.2 A simple method that enables the characterization of cells from a small peripheral whole blood sample could overcome limitations of current analytical techniques. We describe the development of a simple graphene oxide surface coated with single-domain antibody fragments. This format allows quick and efficient capture of distinct WBC subpopulations from small samples (∼30 μL) of whole blood in a geometry that does not require any specialized equipment such as cell sorters or microfluidic devices.

Indexed as

GraphiteHumansNanostructuresSingle-Domain AntibodiesGraphiteSingle-Domain Antibodiesbloodcell detectiongraphene oxidesingle domain antibodysortase

Identifiers

PMID26472062
PMCPMC4715744

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.